Pia Vihinen

2.5k citations
55 papers · 2.0k indexed · 1 hit paper · h-index 21

Pia Vihinen

54 papers receiving 1.9k citations

Hit Papers

Matrix metalloproteinases in cancer: Prognostic markers a...5362002202620102018100200300400500

Peers

Pia Vihinen
Comparison fields: 5 of 113
  • Immunology and Allergy 392
  • Cancer Research 832
  • Oncology 959
  • Molecular Biology 802
  • Hematology 123
Replace Dorina Belotti with:
Dorina Belotti Italy
Pia Nyberg Finland
Pornchai O‐charoenrat Thailand
Claude Allasia France
Kenneth K. Iwata United States
Francesca Margheri Italy
Alexander C. Mackinnon United States
Angela F. Drew United States
Claes G. Tropé Norway
Takayuki Yoshioka Japan
Pia Vihinen relative to Dorina Belotti Italy Dorina Belotti's profile →
Citations per field
00.5×
Dorina Belotti · 1×
Citations per year

Countries citing papers authored by Pia Vihinen

Since Specialization
Citations

This map shows the geographic impact of Pia Vihinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Vihinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Vihinen more than expected).

Fields of papers citing papers by Pia Vihinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Vihinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Vihinen. The network helps show where Pia Vihinen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pia Vihinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pia Vihinen Line = papers co-authored together Pia Vihinen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20241
3 20224
4 202021
5 201914
6 201620
7 20129
8 201217
9 201114
10 20106
11 201043
12 200827
13 200813
14 200624
15 200557
16 2005230
17 200467
18 200311
19 199843
20 1995104

About Pia Vihinen

Pia Vihinen is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 55 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (16 papers), Protease and Inhibitor Mechanisms (14 papers), Cell Adhesion Molecules Research (13 papers), Immunotherapy and Immune Responses (9 papers), Peptidase Inhibition and Analysis (8 papers), Melanoma and MAPK Pathways (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). The work is most often cited by research in Immunology and Allergy (392 citations), Cancer Research (832 citations) and Oncology (959 citations). Pia Vihinen has collaborated with scholars based in Finland, United States and Spain. Frequent co-authors include Veli‐Matti Kähäri, Seppo Pyrhönen, Risto Ala‐aho, Jyrki Heino, Meri‐Sisko Vuoristo, Tatyana Vlaykova, Marjo Hahka‐Kemppinen, Leeni Koivisto, Pirkko Kellokumpu‐Lehtinen and Ilkka Koskivuo. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026